Search hospitals > Missouri > Kansas City
Saint Luke's Hospital of Kansas City
Claim this profileKansas City, Missouri 64111
Global Leader in Breast Cancer
Global Leader in Heart Failure
Conducts research for Lung Cancer
Conducts research for Stroke
Conducts research for Coronary Artery Disease
437 reported clinical trials
44 medical researchers
Summary
Saint Luke's Hospital of Kansas City is a medical facility located in Kansas City, Missouri. This center is recognized for care of Breast Cancer, Heart Failure, Lung Cancer, Stroke, Coronary Artery Disease and other specialties. Saint Luke's Hospital of Kansas City is involved with conducting 437 clinical trials across 555 conditions. There are 44 research doctors associated with this hospital, such as Michael Gibson, Timothy Pluard, Janakiraman Subramanian, and Keith Allen, MD.Area of expertise
1Breast Cancer
Global LeaderHER2 negative
ER positive
Stage IV
2Heart Failure
Global LeaderTop PIs
Michael GibsonVanderbilt University/Ingram Cancer Center5 years of reported clinical research
Studies Squamous Cell Carcinoma
Studies Head and Neck Squamous Cell Carcinoma
18 reported clinical trials
37 drugs studied
Timothy PluardSaint Luke's Cancer Institute LLC2 years of reported clinical research
Studies Breast Cancer
Studies Cancer
13 reported clinical trials
23 drugs studied
Janakiraman SubramanianSaint Luke's Hospital of Kansas City6 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
10 reported clinical trials
20 drugs studied
Keith Allen, MDSaint Luke's Hospital of Kansas City4 years of reported clinical research
Studies Mitral Regurgitation
Studies Mitral Valve Regurgitation
8 reported clinical trials
15 drugs studied
Clinical Trials running at Saint Luke's Hospital of Kansas City
Lung Cancer
Breast Cancer
Heart Failure
Stroke
Amyloidosis
Pancreatic Carcinoma
Atrial Fibrillation
Pancreatic Cancer
Non-Small Cell Lung Cancer
Breast cancer
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
AMG 193 + Other Therapies
for Lung Cancer
The study aims to determine maximum tolerated dose (MTD) or recommended combination dose of the MTA-cooperative PRMT5 inhibitor AMG 193 administered in combination with other therapies in adult participants with metastatic or locally advanced methylthioadenosine phosphorylase (MTAP)-deleted thoracic tumors. The study also aims to determine the safety profile of AMG 193 administered in combination with other therapies in adult participants with metastatic or locally advanced MTAP-deleted thoracic tumors.
Recruiting1 award Phase 16 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Saint Luke's Hospital of Kansas City?
Saint Luke's Hospital of Kansas City is a medical facility located in Kansas City, Missouri. This center is recognized for care of Breast Cancer, Heart Failure, Lung Cancer, Stroke, Coronary Artery Disease and other specialties. Saint Luke's Hospital of Kansas City is involved with conducting 437 clinical trials across 555 conditions. There are 44 research doctors associated with this hospital, such as Michael Gibson, Timothy Pluard, Janakiraman Subramanian, and Keith Allen, MD.
Where is Saint Luke's Hospital of Kansas City located?
**Saint Luke's Hospital of Kansas City**
- **Address:** 4401 Wornall Rd, Kansas City, MO 64111.
- **Parking:** Free patient and visitor parking available in designated areas, including Lot 13 and Parking A at 43rd Street, Entrance C.
Who should I call to ask about financial aid or insurance network?
**Saint Luke's Hospital of Kansas City - Financial Assistance and Insurance Contact Information**
**Financial Assistance:**
- **Phone:** 816-932-5678 or 888-581-9401 (toll-free)
- **Email:** slhsbilling@saintlukeskc.org
- **Website:** [Saint Luke's Financial Assistance](https://www.saintlukeskc.org/saint-lukes-hospital-kansas-city-financial-assistance)
**Insurance:**
- **Phone:** 832-355-3081
- **Website:** [St. Luke's Insurance Information](https://www.stlukeshealth.org/patients-visitors/patients/billing-insurance)
**General Billing Inquiries:**
- **Phone:** 314-576-8100 or 888-924-9200 (toll-free)
- **Fax:** 314-576-8180
- **Address:** St. Luke's Hospital, Attn: Billing Department, 232 S. Woods Mill Road, Chesterfield, MO 63017
For assistance with financial aid applications, insurance queries, and billing concerns, please use the above contacts.
What insurance does Saint Luke's Hospital of Kansas City accept?
Saint Luke's Hospital of Kansas City accepts a wide range of insurance plans, ensuring comprehensive coverage for various patient needs. Among the accepted insurances are Aetna (including Aetna Select HMO, Aetna Choice POS II, and Aetna Missouri Preferred), Blue Cross Blue Shield (including Pathway X, Blue Choice Preferred, and Blue Access), Cigna, Humana, United Healthcare, and many more, covering both national and local plans. It's advised to verify with your insurance carrier that Saint Luke's is an in-network facility and that the planned services are covered by your plan before scheduling any appointments.
What awards or recognition has Saint Luke's Hospital of Kansas City received?
Saint Luke's Hospital of Kansas City is renowned for its healthcare excellence, having been ranked 35th nationally by Consumer's Checkbook in 2002. The hospital boasts a dedicated Office of Research Services, supporting a wide range of research activities. Its research mission emphasizes clinical, translational, and outcomes research to enhance patient care and population health.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.